Status:
COMPLETED
Towards Simple and Non-invasive Assessment of Residual Beta-cell Function in Type 1 Diabetes
Lead Sponsor:
University Hospitals Bristol and Weston NHS Foundation Trust
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18-45 years
Brief Summary
Type 1 diabetes is condition in which progressive autoimmune destruction of insulin-producing beta-cells leads to absolute insulin deficiency. At the time of clinical presentation, it is estimated tha...
Eligibility Criteria
Inclusion
- 1. Type 1 diabetes diagnosed in the last 5 years 2. Age 18-45 years 3. BMI between 18.5 and 29.9 4. Insulin requirement less than 0.8 units/kg
- \-
Exclusion
- 1\. HbA1c higher than 10% 2. Ongoing steroid treatment or chemotherapy 3. Pregnancy and breast feeding 4. eGFR less than 50ml/min/1.73m2
- \-
Key Trial Info
Start Date :
April 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT01227538
Start Date
April 1 2011
End Date
June 1 2013
Last Update
January 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Joint Clinical Research Unit, UHBristol NHS Foundation Trust
Bristol, Avon, United Kingdom, BS1 8HW